Ocugen EBIT per Share
The EBIT per Share of Ocugen (OCGN) as of Oct 20, 2026 is -0.20 USD. In the previous year, EBIT per Share was -0.19 USD — a change of 8.15% (lower).
Get this data via API
Financial Data API
EBIT per Share
-0.20USD
YoY
8.15%
Last updated:
The Ocugen EBIT per Share history
3 Years
10 Years
25 Years
Max
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 1.88USD | +77.95% |
| est | 1.05USD | -519.43% |
| est | -0.25USD | -10.23% |
| est | -0.28USD | +11.90% |
| est | -0.25USD | +22.91% |
| -0.20USD | +8.15% | |
| -0.19USD | -26.31% | |
| -0.26USD | -33.77% | |
| -0.39USD | +31.68% | |
| -0.29USD | +96.50% | |
| -0.15USD | -57.55% | |
| -0.35USD | -96.75% | |
| -10.79USD | -82.70% | |
| -62.36USD | -39.96% | |
| -103.86USD | -27.83% | |
| -143.91USD | -58.85% | |
| -349.70USD | +341.36% | |
| -79.23USD | +12.55% | |
| -70.40USD | +29.70% | |
| -54.28USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Ocugen Stock analysis
Frequently Asked Questions about Ocugen stock
EBIT per Share of Ocugen is -0.20 USD in 2025.
EBIT per Share of Ocugen changed from -0.19 USD to -0.20 USD, representing a 8.15% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Ocugen since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Ocugen
All Key Metrics — Ocugen
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth